glp 1 helps with inflammation GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Comprehensive mechanistic diagram showing GLP-1

Acronyms A1C - Hemoglobin A1C ADA - American Diabetes Association CVD - Cardiovascular disease DM - Diabetes mellitus FBS - Fasting blood sugar GFR - Glomerular filtration rate GI - Gastrointestinal GIP - Glucose-dependent insulinotropic polypeptide GLP-1 - Glucagon-like peptide-1 HFpEF - Heart failure with preserved ejection fraction MASH - Metabolic dysfunctionassociated steatohepatitis NASH - Nonalcoholic steatohepatitis OSA - Obstructive sleep apnea RCT - Randomized controlled trial T2DM - Type 2 diabetes mellitus Thyroid C-cell tumor = Thyroid medullary tumor DRUGS IN CLASS Dual GLP-1 and GIP agonists Tirzepatide (Zepbound) - marketed for weight loss Tirzepatide (Mounjaro) - marketed for diabetes MECHANISM OF ACTION GLP-1 and GIP Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones secreted by intestinal cells in response to eating

Write down what you eat, when, how full you feel, and how the day went

[DOI] [PubMed] [Google Scholar] 65.Salim H

Pagar KR, Darekar AB

[DOI] [PubMed] [Google Scholar] 120.Simsek Y., Cakr I., Yetmis M., Dizdar O.S., Baspinar O., Gokay F